<

ECKERT & ZIEGLER STRAHLEN- UND MEDIZINTECHNIK AG (FRA:EUZ) EQS-News: Eckert & Ziegler: Personnel Changes in the Management. Changes in the Executive Board and Supervisory Board.

Transparency directive : regulatory news

21/11/2023 15:26

EQS-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Personnel
Eckert & Ziegler: Personnel Changes in the Management. Changes in the Executive Board and Supervisory Board.

21.11.2023 / 15:26 CET/CEST
The issuer is solely responsible for the content of this announcement.


Berlin, November 21, 2023. Dr. Hakim Bouterfa, Executive Board member of Eckert & Ziegler AG and responsible for clinical development, will leave the Executive Board of Eckert & Ziegler AG at the end of the year and in future will concentrate exclusively on his tasks as Executive Board member of the Eckert & Ziegler subsidiary Pentixapharm AG (PTX). There he will be supported by Dr. Dirk Pleimes and Anna Steeger, who have been newly appointed to the Executive Board of Pentixapharm AG. Following the consolidation of all clinical activities of the Eckert & Ziegler Group within or below PTX in recent months and following the decision to split-off PTX from the Group, Eckert & Ziegler AG no longer requires the position for clinical development within the Executive Board.

The founder and Chairman of the Supervisory Board of Eckert & Ziegler AG, Dr. Andreas Eckert, will resign from the Supervisory Board in spring 2024 to also join the Executive Board of Pentixapharm AG. He will accompany the announced split-off.

The management of Pentixapharm AG will present an overview of the split-off plans and corresponding measures to the shareholders of Eckert & Ziegler AG on November 27, 2023 at 6 p.m. at the German Equity Forum in Frankfurt, www.eigenkapitalforum.com.

About Eckert & Ziegler.
Eckert & Ziegler Strahlen- und Medizintechnik AG with more than 1.000 employees is a leading specialist for isotope-related components in nuclear medicine and radiation therapy. The company offers a broad range of services and products for the radiopharmaceutical industry, from early development work to contract manufacturing and distribution. Eckert & Ziegler shares (ISIN DE0005659700) are listed in the SDAX index of Deutsche Börse.
Contributing to saving lives.

Your contact:
Eckert & Ziegler AG, Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin, Germany
Tel.: +49 (0) 30 / 94 10 84-138, karolin.riehle@ezag.de, www.ezag.com 

 



21.11.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Eckert & Ziegler Strahlen- und Medizintechnik AG
Robert-Rössle-Str.10
13125 Berlin
Germany
Phone: +49 30 941084-138
Fax: +49 30 941084-112
E-mail: karolin.riehle@ezag.de
Internet: www.ezag.de
ISIN: DE0005659700
WKN: 565970
Indices: SDAX,
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1778651

 
End of News EQS News Service

1778651  21.11.2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1778651&application_name=news&site_id=symex


Other stories

28/05/2024 09:07
28/05/2024 03:29
27/05/2024 23:02
28/05/2024 05:57
28/05/2024 03:30
27/05/2024 21:09
28/05/2024 03:30
27/05/2024 20:00
28/05/2024 03:30
28/05/2024 00:08
28/05/2024 07:22
28/05/2024 07:05
27/05/2024 23:15
27/05/2024 18:59
28/05/2024 04:08
28/05/2024 05:57
28/05/2024 07:00
28/05/2024 08:28
28/05/2024 07:25
27/05/2024 11:41
27/05/2024 19:43
27/05/2024 18:30
28/05/2024 08:16
28/05/2024 00:11
27/05/2024 20:27
27/05/2024 09:59
28/05/2024 03:30
28/05/2024 08:03
28/05/2024 06:01
27/05/2024 22:31
26/05/2024 15:50
27/05/2024 23:47
27/05/2024 10:50
27/05/2024 08:45
27/05/2024 03:30
27/05/2024 15:12
27/05/2024 14:01
27/05/2024 09:32